pdf

O’Melveny’s Representation of Progenics Pharmaceuticals in its Acquisition of Molecular Insight Reported in Daily Journal

January 25, 2013

The January 25, 2013, Daily Journal article “O'Melveny aids pharmaceutical company in all-stock acquisition of cancer drug maker,” reported on O’Melveny’s representation of Progenics Pharmaceuticals Inc. in an all-stock exchange acquisition of Molecular Insight Pharmaceuticals Inc. The Firm’s team was led by partner Jennifer DePalma, counsel Stanton J. Lovenworth, and associate Ruchun Ji.